{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-22-004190","form_type":"8-K","ticker":"PMCB","cik":"0001157075","company_name":"PharmaCyte Biotech, Inc.","filed_at":"2022-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.886588+00:00","generated_at":"2026-06-25T03:48:08.372957+00:00","sec_items":["5.08","8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"PharmaCyte Biotech sets 2022 Annual Meeting for Aug 25; proposals due June 24","bullets":["2022 Annual Meeting of Stockholders scheduled for August 25, 2022.","Stockholder proposals and director nominations must be delivered by June 24, 2022.","Meeting date is more than 30 days from the 2021 annual meeting anniversary."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-22-004190","json":"https://secwatch.observer/filing/0001683168-22-004190.json","markdown":"https://secwatch.observer/filing/0001683168-22-004190.md","text":"https://secwatch.observer/filing/0001683168-22-004190.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1157075/000168316822004190/0001683168-22-004190-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1157075/000168316822004190/pharmacyte_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T03:48:08.372957+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}